|

                  
|
 
In the early 1990s, I began seeking therapies to supplement and replace
the most toxic and least effective therapy in medicine: chemotherapy for
cancer. My colleagues and I identified five groups of ultra-potent, ultra-safe
molecules that enlist the body’s own defenses. We discovered one
of these molecules, carbobenzoxy beta-alanyl-taurine, or COBAT, to be
consistently more than one thousand to one million times more potent by
molecular weight than other anti-fatigue agents. While not indicated to
treat any disease, COBAT is used to manage general fatigue, chronic fatigue-related
syndromes (CFSs), and the fatigue that accompanies illness.
INTRODUCTION
COBAT is a unique compound now being discovered by the medical community
after more than a decade of university research. The structure of COBAT
includes taurine and beta-alanine. However, COBAT’s action exceeds
that of these important amino acids and does not contain any free amino
acids. COBAT is prepared as a classic homeopathic medicine via a series
of 6 to 7 tenfold dilution steps (6X or 7X is homeopathic nomenclature).
COBAT has also been modified to be efficiently absorbed through the oral
mucosa.
According to data presented at the 2003 Whole Person Healing Conference
in Bethesda, MD, COBAT reduced fatigue in approximately 90 percent of
patients with moderate to severe fatigue due to a variety of causes. Patients
experienced a 50 percent improvement in energy levels. In addition, benefits
continued to increase for months.
The uses of COBAT were discovered by researchers at the University of
New Mexico. They found it stimulated inactive cells of the immune system.
Also, Dr. Carol Pontzer’s lab at the University of Maryland found
that COBAT normalized the function of both overly active and inactive
immune cells.
IMMUNE MODULATION, CYTOKINES, AND FATIGUE
COBAT is not a stimulant. Instead, it works by modulating the immune system.
The immune system is controlled by messenger molecules called cytokines,
which are chemicals similar to hormones or neurotransmitters. They control
both the level and type of immune activity. Over a dozen cytokines and
immune cell types must be coordinated to create an optimal immune response.
When the immune system is in balance, an effective defense system results,
while an unbalanced immune system allows the initiation of pathological
conditions. The consensus is that the immune system is a factor in causing
fatigue and other conditions. Scientists describe two major types of immune
responses: Th1 and Th2. Th1 responses fight cancer, viruses, and pathogens.
Th2 responses are often associated with the production of toxic “auto
antibodies” and immune diseases.
One of the toxic, negative effects of unbalanced cytokine production is
fatigue. Fatigue is simply the immune system telling the brain that it
is having difficulty winning the battle against the infection or the problem
it is fighting. When doctors administer drugs that affect cytokines to
fight hepatitis or cancer, a highly toxic reaction called cytokine syndrome
occurs. The unbalanced cytokines cause debilitating fatigue, brain fog,
pain, and depression.
Cytokines produced by the body can also cause these symptoms. At the 38th
annual meeting of the American Academy of Environmental Medicine in 2003,
Aristo Vodjani, Ph.D., of ImmunoScience Laboratories presented studies
on 2,500 patients with chronic fatigue syndrome, fibromyalgia, and Gulf
War Syndrome—all illnesses characterized by fatigue, brain fog,
pain, and depression. Dr. Vodjani found these syndromes had similar cytokine
imbalances. Unfortunately, these people continued to have cytokine imbalances
even after the initiating agent was gone. Thus, the best therapeutic approach
seems to be one favoring the rebalancing of cytokine levels.

HOMEOPATHIC-PROVING TRIAL
In March of 2001, 39 volunteers completed the first homeopathic-proving
trial for COBAT. The study was conducted by David Riley, M.D., Associate
Clinical Professor at the University of New Mexico Medical School. In
this double-blind, placebo-controlled trial, 92 percent of patients given
COBAT had significant physiological effects, versus 26 percent of the
patients given placebo. Reduced fatigue was only one of the benefits suggested
by this study. “Of all the homeopathic provings I have been involved
with (35 trials),” said Dr. Riley, “COBAT produced the strongest
effects.”
SAFETY
COBAT has been found to be non-toxic and safe. However, some people should
not take COBAT. They include those with organ transplants and those on
immunosuppressive therapies such as prescription steroids. Over-the-counter
drugs do not usually interfere with the action of COBAT. Patients with
autoimmune disease should only take COBAT while under special care.
SUGGESTED DOSES
Some people respond to doses as low as 1 to 2 drops per day. On the standard
high dose of 15 drops per day, people may experience feeling over-energized,
have difficulty sleeping, or various aches (headaches, joint aches, etc.).
For such patients, lower doses than suggested are more effective and without
side effects
.
RATE OF IMPROVEMENT AND LENGTH OF BENEFIT
Some patients respond to COBAT immediately with dramatic improvements.
Occasionally, patients go through a cleansing phase during which dose
reduction is appropriate. Many patients have a slow, steady increase in
benefits. On average, a 5 to 10 percent improvement per week can be seen.
Thus, a sufficient trial of one month or more is recommended before determining
efficacy. Data suggests that continued use not only maintains the effect
but also results in progressive improvement over time.
In summary, as assessed by both clinical
trials and in doctor/patient surveys, COBAT is very helpful for decreasing
fatigue without toxicity. COBAT is offered by Allergy Research Group under
the name Taurox SB™ and comes in two strengths: Taurox SB™
6x Enhanced (regular strength) and Taurox SB™ 7x with
Minerals (for hypersensitive individuals).
Back to the top
ABOUT
THE AUTHOR
Floyd Taub, M.D., is a Boardcertified Pathologist. He received his M.D.
from Northwestern University and did his residency at University of Colorado.
He spent 10 years at the National Institutes of Health (NIH) and the National
Cancer Institute. He designed and implemented the first computerized image
processing system to analyze gene expression levels (genomics). He later
founded Digene which developed the new PAP smear, helping women find and
reduce the incidence of cervical cancer. Most recently, Dr. Taub and colleagues
developed, tested, and introduced COBAT.
|
|